VANCOUVER, British Columbia–(BUSINESS WIRE)–SaNOtize Research & Development Corp., a therapeutics technology company based in Vancouver, BC, announced today the start of a Phase 2 safety and efficacy trial of its novel Nitric Oxide Nasal Spray (NONS) for the treatment of recurrent acute rhinosinusitis (RARS).

Read more here.